ClinicalTrials.gg
CompletedNCT04730167Updated Oct 18, 2023

The Monaco Initiative for Concussion in Motorsport Pilots

An observational study in Brain Injuries, Concussion, Brain and Sport Injury, sponsored by Association de Recherche Bibliographique pour les Neurosciences. Completed at 1 site in Monaco. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-18.

Primary conditionBrain ConcussionRegistry: Brain InjuriesReclassifiedWhy we changed it
Registry
Brain Injuries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Brain Concussion
Why
  1. The study's listed conditions name Brain Concussion, a narrower term within Brain Injuries.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Association de Recherche Bibliographique pour les Neurosciences · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
12
Ages
18 Years and older
Sex
All
01

Study summary

The study aims:

  • to observe a population particularly exposed by the past to brain trauma and concussion: Motorsport Pilots who are retired from a professional practice of motor sport;
  • to report results of their neuro-cognitive evaluations,
  • to determine if specific profiles emerge.
  • to evaluate potential consequences of these traumas' history at a cerebral, physical and psychological level.
  • to evaluate the contribution of the various examinations performed as part of a concussion assessment in routine care (eye-tracking, brain imaging, Neuropsychological Assessment).
Read the detailed description

The Memory Center of the Rainier III Center and The Department of Nuclear Medicine of the Princess Grace Hospital are particularly aware of evaluation, management and monitoring of patients who have suffered brain trauma, or concussions, and the study of possible long-term consequences.

They regularly receive patients, referred by neurologists or spontaneously coming for consultation, for whom the carrying out of a complete in-depth evaluation is recommended, because of their medical history and their personal history.

In partnership with the "Fédération Internationale de l'Automobile" (FIA) and the "Automobile Club of Monaco" (ACM), the Princess Grace Hospital team hopes ultimately to set up a screening campaign for traumatic brain injuries among a particularly exposed population: motorsports people.

In this context, inspired by the work carried out by the Cambridge University team (the Rescue Racer Study) and the FIA recommendations, the Sponsor wishes to carry out an observational study with retired motor sportspeople.

The objectives are to study a population particularly exposed by the past to brain trauma and concussion (who is retired from a professional practice of motor sport), to report results of their neuro-cognitive evaluations, and to determine if specific profiles emerge, to evaluate potential consequences of these traumas' history at a cerebral, physical and psychological level.

02

Conditions studied

  • Brain Injuries
  • Concussion, Brain
  • Sport Injury

Browse trials for

Keywords

  • Motorsport Pilots
  • Concussions
  • Brain trauma
  • Traumatic brain injuries
  • MRI
  • positron emission tomography (PET) scan
  • Video-oculography
  • Oculomotor behaviors
03

In context

Brain Concussion Reclassified

637 studies on the registry are indexed under Brain Concussion; 163 are open to participants now.

This study's enrollment of 12 is below the median of 149 across 166 observational studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

Association de Recherche Bibliographique pour les Neurosciences is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Compared within Brain Concussion, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Brain Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Retired motorsport pilots coming to the CHPG for a memory assessment or concussion assessment, meeting the study's inclusion criteria, and volunteering to participate.

All assessments and examinations are carried out in routine care, so study essential data will be collected from the patient's medical file (source file): Demographic data, Medical history, Sport practice History of sports, Results of neurological and neuropsychological assessments, Eye-tracking results, MRI results, PET-FDG results.

Eligibility criteria

  • Men or women.
  • Aged 18 years and older.
  • Retired motor sport pilot (Formula 1 or rally).
  • Expressing a cognitive, memory, somatic, emotional complaint, sleep disorders or a concern following the practice of Motorsport, that motivate carrying out of a memory assessment or a concussion assessment in routine care.
  • Who are willing to participate in the study and give their written .
  • Covered by a health insurance system.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Retired Motorsport Pilots

    Concussion assessment

    Other: Neurological and neuropsychological assessments / MRI / PET scan / Video-oculography.

Interventions

  • OtherNeurological and neuropsychological assessments / MRI / PET scan / Video-oculography.

    Essential data for this study are those collected during the concussion assessment, carried out as part of routine care at Princess Grace Hospital (medical background; history of sports practice and history of concussions; data extracted from clinical and neuropsychological evaluations, from imaging exams (MRI and PET-Scan) and from eye-tracking evaluation).

06

What researchers measure

Primary outcomes

  1. Patients description

    Describe the profile of included patients

    Time frame: Baseline

  2. Medical history of concussion

    Describe the Medical history of concussion of included patients

    Time frame: Baseline

  3. Presence of Post Concussive Symptoms

    Assessed by the Symptoms Scale of the Sport Concussion Assessment Tool (SCAT), composed of 22 post concussive symptom items graded on a scale from 0 (no symptoms) to 6 (severe symptoms), summed to form a symptom severity score (range 0-132).

    Time frame: Baseline

  4. Neurological evaluation

    Assessed by the Neurological exam part of the Sport Concussion Assessment Tool (SCAT), composed of 5 questions.

    Time frame: Baseline

  5. Postural stability

    Assessed by Balance Error Scoring System (BESS). Score of 0-60 (lower scores indicate better balance and less errors)

    Time frame: Baseline

  6. MRI scan

    MRI data are described according to their nature (lesion / atrophy / sequel / signal anomaly), and classified as present or absent.

    Time frame: Baseline

  7. PET/CT scan - Visual analysis

    Description of possible hypometabolic or hypermetabolic areas of the cerebral cortex on the PET / CT images of the subject.

    Time frame: Baseline

  8. PET/CT scan - Parametric analysis

    The uptake values of \[18F\]-2-fluoro-2-deoxy-D-glucose (18-FDG) (average uptake and standard deviation) of several target regions of the subject's cerebral cortex will be entered in comparison with an age-matched database developed in the Scenium software from Siemens Medical Solutions USA® (software version VB30A)

    Time frame: Baseline

  9. PET/CT scan - other description

    Description of any abnormalities found on non-opacified CT slices.

    Time frame: Baseline

  10. Global cognitive performance

    MONTREAL COGNITIVE ASSESSMENT (MOCA) is used to evaluate Global cognitive performance. MOCA is a 30-question general cognitive function assessment. The maximum score is 30. Performance of each participant is compared to their reference sample (depending on age, sex and level study).

    Time frame: Baseline

  11. Episodic memory performance

    The Grober and Buschke Free and Cued recall (16 items) or the Selective Reminding Test are used to evaluate Episodic memory. Performances of each participant are compared to their reference sample (depending on age, sex and level study).

    Time frame: Baseline

  12. Executive performance - Trail Making Test A&B

    Trail Making Test (T.M.T) A\&B is used to evaluate executive performance. The task requires a subject to connect a sequence of 25 consecutive targets on a sheet of paper, in the shortest time possible without lifting the pen from the paper. Time performances of each participant are compared to their reference sample.

    Time frame: Baseline

  13. Executive performance - Stroop test

    Stroop test (GREFFEX) is used to evaluate executive performance and more specifically inhibition. The time to complete each condition (in seconds) is recorded, as well as the number of uncorrected and corrected errors. Stroop task performances of each participant are compared to their reference sample.

    Time frame: Baseline

  14. Executive performance - B.R.E.F.

    The "Batterie rapide d'évaluation frontale" (B.R.E.F.), or Frontal Assessment Battery at Bedside (F.A.B.), is used to determine the presence or not of a cognitive and behavioral dysexecution syndrom. The maximum score is 18. Performances of each participant are compared to their reference sample.

    Time frame: Baseline

  15. Executive performance - The Modified Card Sorting Test of Nelson (MCST)

    The Modified Card Sorting Test of Nelson (MCST) is used to evaluate executive function in patients with focal, traumatic and degenerative brain diseases. Performance on the MCST is scored by computing the number of categories achieved by a participant, and the number of perseverative errors. Performance of each participant are compared to their reference sample.

    Time frame: Baseline

  16. Verbal fluency

    Verbal fluency test is a short test of verbal functioning. It consists of two tasks: category fluency and letter fluency. Participant is given 1 minute to produce as many unique words as possible within a semantic category (category fluency) or starting with a given letter (letter fluency). The participant's score in each task is the number of unique correct words. Performances of each participant are compared to their reference sample.

    Time frame: Baseline

  17. Visuospatial/constructional ability

    Rey-complex copy figure test is used to evaluate visuospatial/constructional abilities. Performance of each participant is compared to their reference sample.

    Time frame: Baseline

  18. Social cognition and Emotional assessment

    The Mini-sea is used to evaluate Social cognition. Evaluation criteria: Scores to Ekman Faces task (1976): total score / 35 and sub-scores / 5. Performances of each participant are compared to their reference sample.

    Time frame: Baseline

  19. Selective and sustained attention

    The d2 Test of Attention is a cancellation test of attention and concentration that measures selective and sustained attention. Participant cross out any letter "d" with two marks around above it or below it in any order. The surrounding distractors are usually similar to the target stimulus, for example a "p" with two marks or a "d" with one or three marks (Ability to concentrate, Processing speed, Percentage of errors). The quotation provides values for the three main indices. Performances of each participant are compared to their reference sample.

    Time frame: Baseline

  20. Storage and handling of information, short term and working memory skill

    The Digit span and spatial span tasks (Empans) assess the storage and handling of information, short term and working memory skill. Participant reads a sequence of numbers and is asked to repeat the same sequence back to the examiner in order (forward span) or in reverse order (backward span). As well for spatial span task. Four scores are obtained (forward and backward verbal scores, forward and backward visuospatial scores). Performances of each participant are compared to their reference sample.

    Time frame: Baseline

  21. Working memory

    Baddeley's dual task assess the ability to coordinate two tasks simultaneously divided attention ability. The score of each participant are compared to their reference sample.

    Time frame: Baseline

  22. A sustained attention and working memory test

    PASAT (Paced Auditory Serial Addition Test) is a sustained attention and working memory test. The results are expressed as a score of 60 points. Performances of each participant are compared to their reference sample.

    Time frame: Baseline

  23. Language

    The "Dénomination d'Objet 80" (DO 80), is an image naming task in order to assess language and visual gnosias.

    Time frame: Baseline

  24. Oculomotor paradigms raw performance - Horizontal saccades Latency

    This concerns saccades Latency (in ms) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device. For each subject value were judged abnormal if they differed by \>1.65 Standard Deviation (SD) compared to their reference sample.

    Time frame: Baseline

  25. Oculomotor paradigms raw performance - Horizontal saccades Main velocity

    This concerns saccades Main velocity (in °/sec) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device. For each subject value were judged abnormal if they differed by \>1.65 Standard Deviation (SD) compared to their reference sample.

    Time frame: Baseline

  26. Oculomotor paradigms raw performance - Horizontal saccades Gain.

    This concerns saccades Gain (gaze accuracy) during horizontal paradigms. Eye movements were recorded and analyzed with an eye-tracking device. For each subject value were judged abnormal if they differed by \>1.65 Standard Deviation (SD) compared to their reference sample.

    Time frame: Baseline

  27. Oculomotor paradigms raw performance - Vertical saccades Latency

    This concerns saccades Latency (in ms) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device. For each subject value were judged abnormal if they differed by \>1.65 SD compared to their reference sample.

    Time frame: Baseline

  28. Oculomotor paradigms raw performance - Vertical saccades Main Velocity

    This concerns saccades Main velocity (in °/sec) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device. For each subject value were judged abnormal if they differed by \>1.65 SD compared to their reference sample.

    Time frame: Baseline

  29. Oculomotor paradigms raw performance - Vertical saccades Gain

    This concerns saccades Gain (gaze accuracy) during vertical paradigms. Eye movements were recorded and analyzed with an eye-tracking device. For each subject value were judged abnormal if they differed by \>1.65 SD compared to their reference sample.

    Time frame: Baseline

  30. Inhibition capacity

    Measure of inhibition capacity performance during an "antisaccades" paradigm. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: percentage of errors. For each subject value were judged abnormal if they differed by \>1.65 SD compared to their reference sample.

    Time frame: Baseline

  31. Internuclear ophthalmoplegia (INO) detection

    Highlight presence/absence of INO. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: INO is present if calculated ratio of abducting to adducting eye movement (both mean and peak velocity) is \>1.

    Time frame: Baseline

  32. Fixations impairments detection

    Highlight presence/absence of Fixations impairments. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: presence/absence/frequency of square wave-jerks, nystagmus, flutters.

    Time frame: Baseline

  33. Impairment of smooth pursuit

    Highlight Impairment of horizontal and vertical smooth pursuit. Eye movements were recorded and analyzed with an eye-tracking device. Evaluation criteria: presence/absence of saccade and perturbation.

    Time frame: Baseline

07

Study locations

1 site
  • Princess Grace Hospital / Department of Nuclear Medicine / Memory Center of the Rainier III Clinical Gerontology Center
    Monaco, 98000, Monaco
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2021 to primary completion in Aug 2023, 22 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 19, 2021
First posted
Jan 29, 2021
StartActual
Oct 5, 2021
Primary completionActual
Aug 5, 2023
CompletionActual
Aug 31, 2023
Last update
Oct 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04730167
Lead sponsor
Association de Recherche Bibliographique pour les Neurosciences
Collaborators
Centre Hospitalier Princesse Grace, University of Cambridge, Institut National de Recherche en Informatique et en Automatique
Responsible party
Sponsor
First posted
Jan 29, 2021
Start date
Oct 5, 2021
Primary completion
Aug 5, 2023
Completion
Aug 31, 2023
Last update
Oct 18, 2023

Study contacts

Benoit PAULMIER
principal investigator · Department of Nuclear Medicine, Princess Grace Hospital, Monaco.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion